丽珠医药(01513.HK)11月4日耗资600万元回购16.47万股A股
Ge Long Hui·2025-11-04 09:36

Core Viewpoint - Lijun Pharmaceutical (01513.HK) announced a share buyback plan, indicating confidence in its stock value and commitment to returning capital to shareholders [1] Group 1: Buyback Details - The company plans to repurchase 164,700 A shares at a total cost of RMB 6 million [1] - The buyback price per share is set between RMB 36.16 and RMB 36.71 [1]